EHRA Premium Access

A platform for assessing pro- and anti-arrhythmic effects of drugs based on isogenic human iPSC-derived cardiomyocytes

Presentation

About the speaker

Doctor Giulia Campostrini

Leiden University Medical Centre, Leiden (Netherlands (The))
0 follower

17 more presentations in this session

The hidden electrophysiological cardiotoxic effects of rofecoxib are prevented by ischaemic preconditioning

Speaker: Doctor Z. Husti (Szeged, HU)

Thumbnail

A high-throughput system to reliably characterize normal human ventricular electrophysiology from living patients

Speaker: Doctor A. Olivan-Viguera (Zaragoza, ES)

Thumbnail

Pros and cons of human iPSC cardiomyocytes in drug testing and disease modelling: insights from computational modelling

Speaker: Doctor J. Koivumaeki (Tampere, FI)

Thumbnail

Advanced morpho-functional analysis on ventricular and atrial tissue reveals sarcomere energetic impairment in hcm patients

Speaker: Miss E. Lazzeri (Florence, IT)

Thumbnail

Istaroxime improves diabetic diastolic dysfunction through SERCA stimulation

Thumbnail

Access the full session

Poster Session 1 - 43rd EWGCCE Meeting

Speakers: Doctor G. Campostrini, Doctor Z. Husti, Doctor A. Olivan-Viguera, Doctor J. Koivumaeki, Miss E. Lazzeri
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk